Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...

An unusual about-face that played out at the FDA over the last week illustrated the power of the “Make America Healthy Again” ...

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) has officially entered the most critical phase of its development ...

Dermatologists say that oral minoxidil pills are one of the most effective treatments available for hair loss in women. Why ...

For Dawn Steiner, 58, a speech pathologist, who participated in the clinical trial, the implant has been a game changer. She ...

This article was featured in One Great Story, New York ’s reading recommendation newsletter. Sign up here to get it nightly.

Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.

While your local thrift shop could make your vintage dishware dreams come true, you want to pause for a second before ...